Advanced Head and Neck Squamous Cell Carcinoma Clinical Trials

13 clinical trials for Advanced Head and Neck Squamous Cell Carcinoma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer — RECRUITING · PHASE2
• Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study — RECRUITING · PHASE4
• IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers — RECRUITING · PHASE1
• CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer — SUSPENDED · PHASE2
• Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin — ACTIVE_NOT_RECRUITING · PHASE1
• A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers — COMPLETED · PHASE1
• Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition — COMPLETED · PHASE2
• Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC — COMPLETED · PHASE2
• Influencing Factors for Physical Activity in People With Head and Neck Cancer — COMPLETED
• PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell Carcinoma — WITHDRAWN · PHASE2
• A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma — TERMINATED · PHASE2

Refine this search